Low density lipoproteins develop resistance to oxidative modification due to inhibition of cholesteryl ester transfer protein by a monoclonal antibody

Journal of Lipid Research

Volumn 41, Issue 1, 2000, Pages 126-133

  Sugano, Masahiro ^a   Sawada, Shojiro ^a   Tsuchida, Keiko ^a   Makino, Naoki ^a   Kamada, Masafumi ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b JAPAN TOBACCO INC   (Japan)

Author keywords

Cholesteryl ester; Cholesteryl ester transfer protein; Fatty acids; LDL oxidation; Triglycerides

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL ESTER; CHOLESTEROL ESTER TRANSFER PROTEIN; COPPER SULFATE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MONOCLONAL ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL TRANSPORT; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LIPID COMPOSITION; LIPID OXIDATION; LIPID TRANSPORT; LIPOPROTEIN METABOLISM; MACROPHAGE; MALE; MOUSE; NONHUMAN; PLASMA; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; CARRIER PROTEINS; CELL LINE; CHOLESTEROL ESTER TRANSFER PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLYCOPROTEINS; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; OXIDATION-REDUCTION;

EID: 0033977988     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Koizumi, J., H. Mabuchi, A. Yoshimura, I. Michishita, M. Takeda, H. Itoh, Y. Sakai, T. Sakai, K, Ueda, and R. Takeda. 1985. Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinemia. Atheroslerosis. 58: 175-186.
2. Inazu, A., M. L. Brown, C. B. Hesler, L. B. Agellon, J. Koizumi, K. Tanaka, Y. Maruhama, H. Mabuhi, and A. R. Tall. 1990. Increased high-density lipoprotein levels caused by a common cholesterylester transfer protein gene mutation. N. Engl. J. Med. 323: 1234-1238.
3. Sugano, M., and N. Makino. 1996. Changes in plasma lipoprotein cholesterol levels by antisense oligodeoxynucleotides against cholesteryl ester transfer protein in cholesterol-fed rabbits. J. Biol. Chem. 271: 19080-19083.
4. Sugano, M., N. Makino, S. Sawada, S. Otsuka, M. Watanabe, H. Okamoto, M. Kamada, and A. Mizushima. 1998. Effect of antisense oligodeoxynucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits. J. Biol. Chem. 273: 5033-5036.
5. Rye, K-A., K. H. Garrety, and P. J. Barter. 1992. Changes in the size of reconstituted high density lipoproteins during incubation with cholesteryl ester transfer protein: the role of apolipoproteins. J. Lipid Res. 33: 215-224.
6. Rye, K. A., N. J. Hime, and P. J. Barter. 1995. The influence of cholesleryl ester transfer protein on the composition, size, and structure of spherical, reconstituted high density lipoproteins. J. Biol. Chem. 270: 189-196.
7. Francone, O. K., L. Rover, and M. Haghpassand. 1996. Increased prebeta-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I transgenes. J. Lipid Res. 37: 1268-1277.
8. Rye, K. A., N. J. Hime, and P. J. Barter. 1997. Evidence that cholesteryl ester transfer protein-mediated reductions in reconstituted high density lipoprotein size involve particle fusion. J. Biol. Chem. 272: 3953-3960.
9. Masson, D., N. Duverger, F. Emmanuel, and L. Lagrost. 1997. Differential interaction of human cholesteryl ester transfer protein with plasma high density lipoproteins (HDLs) from human, control mice, and transgenic mice to human HDL apolipoproteins. Lack of lipid transfer inhibitory activity in transgenic mice expressing human apoA-I. J. Biol. Chem. 272: 24287-24293.
10. Castle, C. K., S. L. Kuiper, W. L. Blake, B. Paigen, K. R. Marotti, and G. W. Melchior. 1998. Remodeling of the HDL in NIDDM: a fundamental role for cholesleryl ester transfer protein. Am. J. Physiol 247: E1091-1098.
11. Yen, F. T., R. J. Deckelbaum, C. J. Mann, Y. L. Marcel, R. W. Milne, and A. R. Tall. 1989. Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody - effects of cholesteryl ester formation and neutral lipid mass transfer in human plasma. J. Clin. Invest. 83: 2018-2024.
12. Guerin, M., E. Bruckert, P. J. Dolphin, G. Turpin, and M. J. Chapman. 1996. Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 16: 763-772.
13. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witztum. 1989. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenecity. N. Engl. J. Med. 320: 915-924.
14. Witztum, J. L., and D. Steinberg. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88: 1785-1792.
15. Holvoet, P., G. Perez, Z. Zhao, E. Brouwers, H. Bernar, and D. Collen. 1995. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease. J. Clin. Invest. 95: 2611-2619.
16. Palinski, W., S. Horkko, S. E. Miller, U. P. Steinbrecher, H. C. Powell, L. K. Curtiss, and J. K. Witztum. 1996. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice-demonstration of epitopes of oxidized low density lipoprotein in human plasma. J. Clin. Invest. 98: 800-814.
17. Yla-Herttuala, S., W. Palinski, M. E. Rosenfeld, S. Parthasarathy, T. E. Carew, S. Butler, J. L. Witztum, and D. Steinberg. 1989. Evidence foi the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84: 1086-1095.
18. Regnstrom, J., J. Nilsson, P. Tornvall, C. Landou, and A. Hamsten. 1992. Susceptibility to low density lipoprotein oxidation and coronary atherosclerosis in man. Lancet. 339: 1183-1186.
19. De Rijke, Y. B., H. F. Verwey, C. J. Vogelezang, E. A. Van der Velde, H. M. Princen, A. Van del Laarse, A. V. Bruschke, and T. J. Van Berkel. 1995. Enhanced susceptibility of low-density lipoproteins to oxidation in coronary bypass patients with progression of atherosclerosis. Clin. Chim. Acta. 243: 137-149.
20. Dieber-Rotheneder, M., H. Puhl, G. Waeg, G. Striegel, and H. Esterbauer. 1991. Effect of oral supplementation with D-α-tocopherol on the vitamin E content of human low density lipoprotein and resistance to oxidation. J. Lipid Res. 32: 1325-1332.
21. Princen, H. M. G., W. Van Duyvenvoorde, R. Buytenhek, A. Van der Laarse, G. Van Poppel, J. A. Gevers Leuven, and V. W. van Hinsbergh. 1995. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arterioscler. Thromb. Vasc. Biol. 15: 325-333.
22. Reaven, P. D., B. J. Grasse, and D. L. Tribble. 1994. Effect of linoleate-enriched and oleate-enriched diets in combination with α-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans. Arterioscler. Thromb. 14: 557-566.
23. Suzukawa, M., M. Abbey, P. R. C. Howe, and P. J. Nestel. 1995. Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages. J. Lipid Res. 36: 473-184.
24. Thomas, M.J., T. Thornburg, J. Manning, K. Hooper, and L. L. Rudel. 1994. Fatty acid composition of low-density lipoprotein influences its susceptibility to autooxidation. Biochemistry. 33: 1828-1834.
25. Mata, P., O. Varela, R. Alonso, C. Lahoz, M. de Oya, and L. Badimon. 1997. Monounsaturated and polyunsaturated n-6 fatty acid-enriched diet modify LDL oxidation and decrease human coronary smooth muscle cell DNA synthesis. Arterioscler. Thromb. Vasc. Biol. 17: 2088-2095.
26. Schreier, L. E., S. Sanguinetti, H. Mosso, G. L. Lopez, L. Siri, and R. W. Wikinski. 1996. Low density lipoprotein composition and oxidability in atherosclerotic cardiovascular disease. Clin. Chem. 29: 479-487.
27. Kato, H., T. Nakanishi, H. Arai, H. I. Nishida, and T. Nishida. 1989. Purification, microheterogeneity, and stability of human lipid transfer protein. J. Biol. Chem. 264: 4082-4087.
28. Hesler, C.B., A. R. Tall, T. L. Swenson, P. K. Weech, Y. L. Marcel, and K. W. Milne. 1988. Monoclonal antibodies to the Mr 74,000 cholesteryl ester transfer protein neutralize all of the cholesteryl ester and triglyceride transfer activities in human plasma. J. Biol. Chem. 263: 5020-5023.
29. Sugano, M., N. Makino, and T. Yanaga. 1997. Effect of dietary omega-3 eicosapentaenoic acid supplements on cholesteryl ester transfer from HDL in cholesterol-fed rabbits. Biochim. Biophys. Acta. 1346: 17-24.
30. Parks, J. S., and B.C. Bullock. 1987. Effect of fish oil versus lard diets on the chemical and physical properties of low density lipoproteins of nonhuman primates. J. Lipid Res. 28: 173-182.
31. Barua, A., and H. Furr. 1992. Extraction and analysis by high-performance liquid chromatography of carotenoids in human serum. Methods Enzymol. 213: 273-281.
32. Buege, J. A., and S. D. Aust. 1978. Microsomal lipid peroxidation. Methods Enzymol. 52: 302-310.
33. Esterbauer, H., G. Striegel, H. Puhl, and Rotheneder M. 1989. Continuous monitoring of vitro oxidation of human low density lipoprotein. Free Radical Res. Commun. 6: 67-75.
34. Reaven, P., S. Parthasarathy, B. J. Grasse, E. Miler, F. Almazan, F. H. Mattson, J. C. Khoo, D. Steinberg, and J. L. Witztum. 1991. Feasability of using an oleate-rich diet to reduce the susceptibility of low density lipopiotein to oxidative modification in humans. Am. J. Clin. Nutr. 54: 701-706.
35. Bonanome, A., A. Pagnon, S. Biffanti, A. Opportruno, F. Sorgato, M. Dorella, M. Maiorino, and F. Ursini. 1992. Effect dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoprotein to oxidative modification. Arterioscler. Thromb. 12: 529-533.
36. Abbey, M., G. B. Belling, M. Noakes, F. Hirata, and P. J. Nestel. 1993. Oxidation of low density lipoproteins: intraindividual variability and the effect of dietary linoleate supplementation. Am. J. Clin. Nutr. 57: 391-398.
37. Reaven, P. D., S. Parthasarathy, B. J. Grasse, E. Miler, D. Steinberg, and J. Witztum. 1993. Effects of oleate-rich and linoleate-rich diets on the the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. J. Clin. Invest. 91: 668-676.
38. Ross, R. 1986. The pathogenesis of atherosclerosis: an update. N. Engl. J. Med. 314: 488-500.
39. Brown, G., J. J. Albers, L. D. Fisher, S. M. Schaefer, J. T. Lin, C. Kaplan, X. Q. Zhao, B. D. Bisson, V. F. Fitzpatrick, and H. T. Dodge. 1990. Regression of coronary artery disease as a result of intense lipid-lowering therapy in men with high levels of apolipoprotein B. N. Engl. J. Med. 323: 1289-1298.
40. Holvoet, P., G. Theilmeier, B. Shivalkar, W. Flameng, and D. Collen. 1998. LDL hypercholesteroterolemia is associated with acumulation of oxidized LDL, atherosclerotic plaque growth, and compensatory vessel enlargement in coronary arteries of miniature pigs. Arterioslcer. Thromb. Vasc. Biol. 18: 415-422.
41. Holvoet, P., and D. Collen. 1994. Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J. 8: 1279-1284.
42. Rimm, E. B., M. J. Stampfer, A. Ascherio, E. Giovannucci, G. A. Colditz, and W. C. Willet. 1993 Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 328: 1450-1456.
43. Stampfer, M. J., C. H. Hennekens, J. E. Manson, G. A. Golditz, B. Rosner, and W.C. Willet. 1993. Vitamin E consumption and the risk of coronary bean disease in women. N. Engl. J. Med. 328: 1444-1449.
44. Sevanian, A., J. Hwang, H. Hodis, G. Cazzolato, P. Avogaro, and G. Bittolo-Bon. 1996. Contribution of an in vivo oxidized LDL to LDL oxidation and its association with dense LDL subpopulation. Arterioscler. Thromb. Vasc. Biol. 16: 784-793.
45. Ikewaki, K., M. Nishiwaki, I. Sakamoto, I. Ishikawa, T. Fairwell, L. A. Zech, M. Nagano, H. Nakamura, H. B. Brewer, Jr., and D. J. Rader. 1995. Increased catabolic rate of low density lipoproteins in humans with cholesleryl ester transfer protein deficiency. J. Clin. Invest. 96: 1573-1581.
46. Oliveira, H. C. F., L. Ma, R. Milne, S. M. Marcovina, A. Inazu, H. Mabuchi, and A. R. Tall. 1997. Cholesteryl ester transfer protein activity enhances plasma cholesteryl ester formation. Arterioscler. Thromb. Vasc. Biol. 17: 1045-1052.
47. Maroutti, K. R., C. K. Castle, T. P. Boyle, A. H. Lin, R. W. Murray and G. W. Melchior. 1993. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature (London). 364: 73-75.
48. Foger, B., G. Luef, A. Ritsch, C. Schmidauer, A. Doblinger, F. Lechleitner, F. Aichner, and J. R. Patsch. 1995. Relationship of high-density lipoprotein subfractions and cholesteryl ester transfer protein in plasma to carotid artery wall thickness. J. Mol. Med. 73: 369-372.
49. Hayek, T., L. Masucci-Magoulas, X. Jiang, A. Walsh, E. Rubin, J. L. Breslow, and A. R. Tall. 1995. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing chloresteryl ester transfer protein transgene. J. Clin. Invest. 96: 2071-2074.
50. Hirano, K., S. Yamashita, N. Sakai, T. Arai, Y. Yoshida, S. Nozaki, K. Kumeda-Takemura, and Y. Matsuzawa. 1995. Molecular defect and atherogenicity in cholesteryl ester transfer protein deficiency, Ann. NY Acad. Sci. 748: 599-602.
51. Tall, A. R. 1995. Plasma cholesteryl ester transfer protein and high-density lipoproteins: new insights from molecular genetic studies. J. Intern. Med. 237: 5-12.
52. Zhong, S., D. S. Sharp, J. S. Grove, C. Bruce, K. Yano, J. D. Curb, and A. R. Tall. 1996. Increased coronary heart disease in Japanese- American men with mutation in cholesteryl ester transfer protein gene despite increased HDL levels. J. Clin. Invest. 97: 2917-2923.
53. Hirano, K., S. Yamashita, N. Nakajima, T. Arai, I. Murayama, Y. Yoshida, M. Ishigami, N. Sakai, K. Kameda-Takemura, and V. Matsuzawa. 1997. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area in Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutatuin is not associated with longevity. Arterioscler. Thromb. Vasc. Biol. 17: 1053-1059.
54. Kuivenhoven, J. .A., J. W. Jukema, A. H. Zwinderman, P. der Knijff, R. McPherson, A. V. Bruschke, K. I. Lie, and J. L. Kastelein. 1998. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The regression grouth evaluation statin study group. N. Engl. J. Med. 338: 86-93.
55. Gordon, D. J., and B. M. Rifkind. 1989. High density lipoprotein -the clinical implications of recent studies. N. Engl. J. Med. 321: 1311-1316.